Wuhan iRegene Therapeutics Co., Ltd. announced that it has received $15,700,000 in funding led by Changjiang Securities Company Limited on January 24, 2022. The transaction included participation from other investors.
Changjiang Securities Company Limited
Equities
000783
CNE000000SH3
Investment Banking & Brokerage Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.67 CNY | -1.56% | -0.87% | +5.39% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.39% | 4.33B | |
-7.05% | 28.47B | |
-7.53% | 15.66B | |
+3.15% | 14.47B | |
+44.90% | 12.86B | |
-14.12% | 12.28B | |
-4.02% | 9.02B | |
-12.62% | 7.04B | |
+8.34% | 5.99B | |
-5.04% | 5.68B |
- Stock Market
- Equities
- 000783 Stock
- News Changjiang Securities Company Limited
- Wuhan iRegene Therapeutics Co., Ltd. announced that it has received $15.700000 million in funding from Changjiang Securities Company Limited and other investors.